Search - tctmd.com

Displaying 121 - 140 of 8900

Sort: Relevancy | Date

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Presenter: Mitchell W. Krucoff

October 27, 2025

Presentation TCT 2025

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Presenter: Ben Saville

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

Presenter: Eric A. Secemsky

October 26, 2025

Presentation TCT 2025

The Conformal LAAC Device: Status Update and Current IDE Clinical Trial

Presenter: William A. Gray

October 26, 2025

Presentation TCT 2025

TCT 649: Five-Year Clinical Outcomes of the Randomized Controlled Trial of Angiography Versus Pressure Ratio-Guided Enhancement Techniques - Fractional Flow Reserve (TARGET-FFR)

Presenter: Damien Collison

October 26, 2025

Presentation TCT 2025

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Presenter: Jonathan G. Schwartz

October 26, 2025

Presentation TCT 2025

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Presenter: Sureja Sundaralingam

October 26, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation TCT 2025

TCT 1213: Association between Clinical Trial Participation and in-hospital outcomes with Tricuspid Transcatheter Edge-to-Edge Repair and: A Nationwide Analysis

Presenter: Ahmed Younes

October 26, 2025

Presentation TCT 2025

Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights from the SYMPHONY PE Trial

Presenter: Sripal Bangalore

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

TCT 935: AI-Powered Chatbot for Symptom Monitoring in Post-PCI Care: A Clinical Trial Demonstrating Improved Triage and Reduced Hospitalizations

Presenter: Badri Vinayak Mishra

October 26, 2025

Presentation TCT 2025

First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

Presenter: Leonardo de Oliveira Harduin

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Advertisement

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

The Conformal LAAC Device: Status Update and Current IDE Clinical Trial

TCT 649: Five-Year Clinical Outcomes of the Randomized Controlled Trial of Angiography Versus Pressure Ratio-Guided Enhancement Techniques - Fractional Flow Reserve (TARGET-FFR)

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

TCT 1213: Association between Clinical Trial Participation and in-hospital outcomes with Tricuspid Transcatheter Edge-to-Edge Repair and: A Nationwide Analysis

Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights from the SYMPHONY PE Trial

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

TCT 935: AI-Powered Chatbot for Symptom Monitoring in Post-PCI Care: A Clinical Trial Demonstrating Improved Triage and Reduced Hospitalizations

First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content